Randomized Clinical Trials in Soft Tissue Sarcoma

Surgical Oncology Clinics of North America

Volumn 19, Issue 1, 2010, Pages 1-11

  Katz, Steven C ^a   Brennan, Murray F ^b  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Radiation therapy; Soft tissue sarcoma; Surgery

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; GEMCITABINE; IFOSFAMIDE; MESNA;

ADJUVANT THERAPY; ALOPECIA; BRACHYTHERAPY; BRAIN DISEASE; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; HEMORRHAGIC CYSTITIS; HIGH RISK PATIENT; HUMAN; LEUKOPENIA; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PERITONEUM CANCER; PERITONEUM SARCOMATOSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; REVIEW; SOFT TISSUE SARCOMA; UNSPECIFIED SIDE EFFECT; WOUND COMPLICATION;

HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SARCOMA;

EID: 70449365387     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.09.006     Document Type: Review

References (19)

1. Cancer facts and figures. In: American Cancer Society. Available at: (2006). http://www.cancer.org Accessed April 26, 2009
2. Rosenberg S.A., Tepper J., Glatstein E., et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196 (1982) 305
3. Singer S., Antonescu C.R., Riedel E., et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 238 (2003) 358
4. Pisters P.W., Harrison L.B., Leung D.H., et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14 (1996) 859
5. Yang J.C., Chang A.E., Baker A.R., et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16 (1998) 197
6. O'Sullivan B., Davis A.M., Turcotte R., et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359 (2002) 2235
7. Davis A.M., O'Sullivan B., Turcotte R., et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75 (2005) 48
8. Antman K., Crowley J., Balcerzak S.P., et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 11 (1993) 1276
9. Bramwell V., Rouesse J., Steward W., et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 12 (1994) 1137
10. Frustaci S., Gherlinzoni F., De Paoli A., et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 19 (2001) 1238
11. Santoro A., Tursz T., Mouridsen H., et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 13 (1995) 1537
12. Pervaiz N., Colterjohn N., Farrokhyar F., et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113 (2008) 573
13. Petrioli R., Coratti A., Correale P., et al. Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma. Am J Clin Oncol 25 (2002) 468
14. Bonvalot S., Cavalcanti A., Le Pechoux C., et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol 31 (2005) 917
15. Mace J.R., Keohan M.L., Bernardy H., et al. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide. Clin Cancer Res 9 (2003) 5829
16. Lorigan P., Verweij J., Papai Z., et al. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 25 (2007) 3144
17. Gortzak E., Azzarelli A., Buesa J., et al. A randomized phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 37 (2001) 1096-1103
18. Canter R.J., Qin L.X., Ferrone C.R., et al. Why do patients with low-grade soft tissue sarcoma die?. Ann Surg Oncol 15 (2008) 3550
19. Maki R.G., Wathen K.J., Patel S.R., et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Onc 19 (2007) 2755-2763